{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/neuropathic-pain-drug-treatment/prescribing-information/capsaicin-cream/","result":{"pageContext":{"chapter":{"id":"56e4231d-ab93-5963-bc8a-989240189179","slug":"capsaicin-cream","fullItemName":"Capsaicin cream","depth":2,"htmlHeader":"<!-- begin field 0b9f6a58-ccba-416a-a678-cfa2bbdf006f --><h2>Capsaicin cream</h2><!-- end field 0b9f6a58-ccba-416a-a678-cfa2bbdf006f -->","summary":"","htmlStringContent":"<!-- begin item e0f60f4c-1ba3-4ef7-963e-e2f354910237 --><!-- end item e0f60f4c-1ba3-4ef7-963e-e2f354910237 -->","topic":{"id":"b1f9c908-6cb6-5afd-a737-0a621c6232d0","topicId":"35e3d915-8243-4418-a7dd-6590d8ca5c85","topicName":"Neuropathic pain - drug treatment","slug":"neuropathic-pain-drug-treatment","lastRevised":"Last revised in December 2020","chapters":[{"id":"0c243e96-3697-5ee3-98c7-9ffecf07f2af","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"94d784c6-0537-5187-a548-a95e6ad2f899","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"855f03f8-54cb-5675-a6b8-aeb8064288d7","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"f0b9b63a-bd52-51b6-8eda-cb26c9f551a0","slug":"changes","fullItemName":"Changes"},{"id":"2e3e3fff-20af-56ab-b8f8-a9ee4f14f833","slug":"update","fullItemName":"Update"}]},{"id":"80218328-d006-5b34-a01a-0ef4dbeaf7d5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"22989c5e-df85-5aba-bd66-8c44723e59d7","slug":"goals","fullItemName":"Goals"},{"id":"722de221-9258-5985-8a02-c088cf258a12","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"bf3b0c22-2d82-5464-bf76-bc066dae256f","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"c6576f2f-fd04-5900-a5e1-517233523e2c","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dd2de31a-79d5-5c20-9132-c99c41c12822","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"148cc621-37d8-5264-a358-c380fcfb4223","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"eddf36b3-7bc8-53c9-9c59-fa36b809f229","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"025ef443-81b5-565d-8240-d76615c27e55","slug":"definition","fullItemName":"Definition"},{"id":"3704349e-d3ae-5a8b-ba94-9da5282ed77f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"e18339e8-95d0-582f-ad51-0614dae8f855","slug":"complications","fullItemName":"Complications"},{"id":"9b552f08-01aa-583d-900b-9cbdc90fe28d","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"21d7485a-b855-5ba4-82bc-ca3154184325","fullItemName":"Management","slug":"management","subChapters":[{"id":"bad22859-57ae-5c1c-a944-c3d9fef6d160","slug":"neuropathic-pain-drug-treatment","fullItemName":"Scenario: Neuropathic pain - drug treatment"}]},{"id":"0d8cb386-e038-5d6f-83af-81664da82cca","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"a91a8f28-db46-58e8-9df7-f30be0f00f2b","slug":"amitriptyline","fullItemName":"Amitriptyline"},{"id":"382b9603-7b46-57d1-9b07-fa743886796e","slug":"pregabalin","fullItemName":"Pregabalin"},{"id":"498f1249-e619-5b41-b42b-1a914239d269","slug":"gabapentin","fullItemName":"Gabapentin"},{"id":"201a6fcc-11c6-5f00-b820-7fa69ee8b95d","slug":"duloxetine","fullItemName":"Duloxetine"},{"id":"56e4231d-ab93-5963-bc8a-989240189179","slug":"capsaicin-cream","fullItemName":"Capsaicin cream"},{"id":"01a263c7-9fe1-5a29-95ec-24e56c0c1bc9","slug":"tramadol","fullItemName":"Tramadol"}]},{"id":"9ed9a9fb-0b52-50ef-8980-c1303531094d","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"4fd6ab13-09e0-57f4-a265-464eeab8c835","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"3eb7f136-ffd0-5f27-b2d1-21b49247596d","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"606fc7bf-da44-5385-95f8-0139b3c57ef7","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"9fc3997f-80c3-5333-b5bd-3b3a518bdde6","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"74708745-26ce-5fd4-8c02-67ba25b5a355","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"4f5855b4-c905-54ca-b02a-820f8fdd4a4a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"f09723db-fe39-5bbd-b643-d063fcd61d42","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"0d8cb386-e038-5d6f-83af-81664da82cca","slug":"prescribing-information","fullItemName":"Prescribing information"},"subChapters":[{"id":"387194ab-a22f-55f1-a0a8-f67f5bb4e62f","slug":"licensed-indications","fullItemName":"Licensed indications","depth":3,"htmlHeader":"<!-- begin field 41161065-de20-4462-8876-ab3d00917104 --><h3>Is capsaicin licensed for neuropathic pain?</h3><!-- end field 41161065-de20-4462-8876-ab3d00917104 -->","summary":"","htmlStringContent":"<!-- begin item bc5f00ed-bbca-4f6d-8ebf-ab3d009170a4 --><!-- begin field dd1f1257-778c-432a-9388-ab3d00917104 --><ul><li>Capsaicin 0.075% cream (Axsain<sup>®</sup>) is licensed for the symptomatic relief of postherpetic neuralgia after open skin lesions have healed, and for the symptomatic relief of painful diabetic neuropathy (only under the direct supervision of a hospital consultant who has access to specialist resources) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">ABPI, 2019b</a>]. </li><li>However, the National Institute for Health and Care Excellence recommends capsaicin cream for people with localized neuropathic pain who wish to avoid, or cannot tolerate, oral treatments [<a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">NICE, 2019a</a>]. </li></ul><!-- end field dd1f1257-778c-432a-9388-ab3d00917104 --><!-- end item bc5f00ed-bbca-4f6d-8ebf-ab3d009170a4 -->","subChapters":[]},{"id":"94249b4f-8021-5154-bb6d-cbc55f8c007a","slug":"dose","fullItemName":"Dose","depth":3,"htmlHeader":"<!-- begin field 5d6a3291-fb30-4807-a9f2-ab3d00918865 --><h3>Dose </h3><!-- end field 5d6a3291-fb30-4807-a9f2-ab3d00918865 -->","summary":"","htmlStringContent":"<!-- begin item 8f59ca50-d6dd-42e6-8d0c-ab3d0091883c --><!-- begin field cb9d36d8-4a24-4a8d-b25d-ab3d00918865 --><ul><li>Advise the person to apply a small amount of cream (pea size) to the affected area 3–4 times a day (not more often than every 4 hours).<ul><li>Review treatment after 8 weeks.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">ABPI, 2019b</a>] </p><!-- end field cb9d36d8-4a24-4a8d-b25d-ab3d00918865 --><!-- end item 8f59ca50-d6dd-42e6-8d0c-ab3d0091883c -->","subChapters":[]},{"id":"2d6b28e5-f3b3-563b-8d0b-cac5529015ab","slug":"contraindications-cautions","fullItemName":"Contraindications and cautions","depth":3,"htmlHeader":"<!-- begin field 59c1fd98-4b20-40c7-b380-ab3d0091ed6e --><h3>Contraindications and cautions </h3><!-- end field 59c1fd98-4b20-40c7-b380-ab3d0091ed6e -->","summary":"","htmlStringContent":"<!-- begin item fb4eb6e1-2042-4eba-aad9-ab3d0091ed49 --><!-- begin field 77f88de1-db6b-4222-85d5-ab3d0091ed6e --><ul><li>Avoid using capsaicin cream on:<ul><li>Broken skin.</li><li>Inflamed skin.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">ABPI, 2019b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field 77f88de1-db6b-4222-85d5-ab3d0091ed6e --><!-- end item fb4eb6e1-2042-4eba-aad9-ab3d0091ed49 -->","subChapters":[]},{"id":"18149a10-b4ca-526e-9346-894d02484877","slug":"adverse-effects","fullItemName":"Adverse effects","depth":3,"htmlHeader":"<!-- begin field b16b05f5-f42d-4631-964b-ab3d0092086f --><h3>Adverse effects</h3><!-- end field b16b05f5-f42d-4631-964b-ab3d0092086f -->","summary":"","htmlStringContent":"<!-- begin item 783c5ee8-565f-469b-9801-ab3d0092084a --><!-- begin field 6fd888cd-6546-47d2-82bc-ab3d0092086f --><ul><li>Adverse effects include:<ul><li>Skin irritation or transient burning on application (more common when used more than four times daily).</li><li>Irritation of mucous membranes of the eyes and respiratory tract: coughing, sneezing, and watering eyes.<ul><li>Dyspnoea, wheezing, exacerbation of asthma have also been reported.</li></ul></li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">ABPI, 2019b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">Joint Formulary Committee, 2020</a>]</p><!-- end field 6fd888cd-6546-47d2-82bc-ab3d0092086f --><!-- end item 783c5ee8-565f-469b-9801-ab3d0092084a -->","subChapters":[]},{"id":"c2fb2fb8-8ccf-5d89-861a-61cf479ea8db","slug":"drug-interactions","fullItemName":"Drug interactions","depth":3,"htmlHeader":"<!-- begin field 7762ed06-2fac-4877-8c6e-ab3d009239cc --><h3>Drug interactions</h3><!-- end field 7762ed06-2fac-4877-8c6e-ab3d009239cc -->","summary":"","htmlStringContent":"<!-- begin item 545063b5-7cba-4d91-9cf4-ab3d0092399b --><!-- begin field 7766006c-f36b-4d67-adf3-ab3d009239cc --><ul><li>There are no known drug interactions with capsaicin cream.</li></ul><!-- end field 7766006c-f36b-4d67-adf3-ab3d009239cc --><!-- end item 545063b5-7cba-4d91-9cf4-ab3d0092399b -->","subChapters":[]},{"id":"281aa36f-6ba8-5d6d-b21a-9334f623c93d","slug":"pregnancy-breastfeeding","fullItemName":"Pregnancy and breastfeeding","depth":3,"htmlHeader":"<!-- begin field 21891865-8246-4f3d-83ea-ab3d00921a57 --><h3>Pregnancy and breastfeeding</h3><!-- end field 21891865-8246-4f3d-83ea-ab3d00921a57 -->","summary":"","htmlStringContent":"<!-- begin item d956dad2-dd5e-439a-8b9b-ab3d00921a1d --><!-- begin field a5d288d1-9db6-4d41-9bb7-ab3d00921a57 --><ul><li>According to the manufacturer, although there have been no studies looking at the safety of capsaicin cream during pregnancy and breastfeeding, the small amount absorbed transdermally is considered unlikely to cause any adverse effects in humans.</li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">ABPI, 2019b</a>] </p><!-- end field a5d288d1-9db6-4d41-9bb7-ab3d00921a57 --><!-- end item d956dad2-dd5e-439a-8b9b-ab3d00921a1d -->","subChapters":[]},{"id":"8ad5f729-91bb-5cfa-9c68-caa1b371dc0c","slug":"other-prescribing-issues","fullItemName":"Other prescribing issues","depth":3,"htmlHeader":"<!-- begin field 9383bcc3-f569-4466-b9ad-ab3d009486e2 --><h3>Other prescribing issues</h3><!-- end field 9383bcc3-f569-4466-b9ad-ab3d009486e2 -->","summary":"","htmlStringContent":"<!-- begin item c35aee7a-d00d-4d6b-b224-ab3d009486c1 --><!-- begin field 62b9f860-4ee5-4d97-8fde-ab3d009486e2 --><ul><li>Advise the person:<ul><li>That the cream should be gently rubbed in, and there should be no residue left on the surface of the skin.</li><li>To wash their hands immediately after applying capsaicin cream unless the hands are the treated areas, in which case they should be washed 30 minutes after application.</li><li>To avoid inhalation of vapours from the cream as transient irritation of the mucous membranes of the eyes and respiratory tract (including exacerbation of asthma) has been reported.</li><li>That capsaicin cream should not be applied near the eyes.</li><li>That tight bandages should not be applied on top of capsaicin cream.</li><li>That medical advice should be sought if the condition worsens.</li></ul></li></ul><p>[<a class=\"bibliography-reference internal-reference\" href=\"/topics/neuropathic-pain-drug-treatment/references/\">ABPI, 2019b</a>]</p><!-- end field 62b9f860-4ee5-4d97-8fde-ab3d009486e2 --><!-- end item c35aee7a-d00d-4d6b-b224-ab3d009486c1 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}